OIP5 and breast cancer: For example, overexpression of Mis18β has been frequently observed in several cancer types including breast cancer, clear cell renal cell carcinoma, hepatic, gastric and colorectal cancers and this correlates with disease progression, poor prognosis, and low overall survival rate.45–50